Trade Mark Journal No.2026/010 6 March 2026

Mark 2

RE-AIM THERAPEUTICS

Class 5

Pharmaceuticals; therapeutics; pharmaceuticals and therapeutics for the treatment of autoimmune diseases; pharmaceuticals and therapeutics for the treatment of inflammatory diseases and conditions; pharmaceuticals and therapeutics for the treatment of irritable bowel disease, metabolic disorders, psoriasis, psoriatic arthritis, hidradenitis suppurativa and ankylosing spondylitis.